Multi-level Proteomics Identifies CT45 as a Chemosensitivity Mediator and Immunotherapy Target in Ovarian Cancer

Most high-grade serous ovarian cancer (HGSOC) patients develop resistance to platinum-based chemotherapy and recur, but 15% remain disease free over a decade. To discover drivers of long-term survival, we quantitatively analyzed the proteomes of platinum-resistant and -sensitive HGSOC patients from minute amounts of formalin-fixed, paraffin-embedded tumors. This revealed cancer/testis antigen 45 (CT45) as an independent prognostic factor associated with a doubling of disease-free survival in advanced-stage HGSOC. Phospho- and interaction proteomics tied CT45 to DNA damage pathways through direct interaction with the PP4 phosphatase complex. In vitro, CT45 regulated PP4 activity, and its high expression led to increased DNA damage and platinum sensitivity. CT45-derived HLA class I peptides, identified by immunopeptidomics, activate patient-derived cytotoxic T cells and promote tumor cell killing. This study highlights the power of clinical cancer proteomics to identify targets for chemo- and immunotherapy and illuminate their biological roles.

[1]  Eilon Barnea,et al.  Human Leukocyte Antigen (HLA) Peptides Derived from Tumor Antigens Induced by Inhibition of DNA Methylation for Development of Drug-facilitated Immunotherapy * , 2016, Molecular & Cellular Proteomics.

[2]  Bert Vogelstein,et al.  PD-1 Blockade in Tumors with Mismatch-Repair Deficiency. , 2015, The New England journal of medicine.

[3]  G. von Heijne,et al.  Tissue-based map of the human proteome , 2015, Science.

[4]  Morten Nielsen,et al.  Gapped sequence alignment using artificial neural networks: application to the MHC class I system , 2016, Bioinform..

[5]  O. Lund,et al.  The MHC Motif Viewer: A Visualization Tool for MHC Binding Motifs , 2010, Current protocols in immunology.

[6]  Michael L. Gatza,et al.  Proteogenomics connects somatic mutations to signaling in breast cancer , 2016, Nature.

[7]  E. Hafen,et al.  A Novel, Evolutionarily Conserved Protein Phosphatase Complex Involved in Cisplatin Sensitivity*S , 2005, Molecular & Cellular Proteomics.

[8]  E. Lengyel,et al.  Genomics of Ovarian Cancer Progression Reveals Diverse Metastatic Trajectories Including Intraepithelial Metastasis to the Fallopian Tube. , 2016, Cancer discovery.

[9]  Chunaram Choudhary,et al.  DNA Repair Network Analysis Reveals Shieldin as a Key Regulator of NHEJ and PARP Inhibitor Sensitivity , 2018, Cell.

[10]  Chris Sander,et al.  Emerging landscape of oncogenic signatures across human cancers , 2013, Nature Genetics.

[11]  Morten Nielsen,et al.  Simultaneous alignment and clustering of peptide data using a Gibbs sampling approach , 2013, Bioinform..

[12]  Joshua LaBaer,et al.  PSI:Biology-materials repository: a biologist’s resource for protein expression plasmids , 2011, Journal of Structural and Functional Genomics.

[13]  Benjamin J. Raphael,et al.  Integrated Genomic Analyses of Ovarian Carcinoma , 2011, Nature.

[14]  Matthias Mann,et al.  High recovery FASP applied to the proteomic analysis of microdissected formalin fixed paraffin embedded cancer tissues retrieves known colon cancer markers. , 2011, Journal of proteome research.

[15]  George Coukos,et al.  Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. , 2003, The New England journal of medicine.

[16]  M. Mann,et al.  SCAI promotes DNA double-strand break repair in distinct chromosomal contexts , 2016, Nature Cell Biology.

[17]  R Core Team,et al.  R: A language and environment for statistical computing. , 2014 .

[18]  R. Cress,et al.  Characteristics of Long-Term Survivors of Epithelial Ovarian Cancer , 2015, Obstetrics and gynecology.

[19]  Yunfeng Pan,et al.  A PP4 phosphatase complex dephosphorylates RPA2 to facilitate DNA repair via homologous recombination , 2010, Nature Structural &Molecular Biology.

[20]  M. Mann,et al.  Integrative proteomic profiling of ovarian cancer cell lines reveals precursor cell associated proteins and functional status , 2016, Nature Communications.

[21]  V. Beral,et al.  Rethinking ovarian cancer II: reducing mortality from high-grade serous ovarian cancer , 2015, Nature Reviews Cancer.

[22]  Lloyd J. Old,et al.  Cancer/testis antigens, gametogenesis and cancer , 2005, Nature Reviews Cancer.

[23]  Morten Nielsen,et al.  Seq2Logo: a method for construction and visualization of amino acid binding motifs and sequence profiles including sequence weighting, pseudo counts and two-sided representation of amino acid enrichment and depletion , 2012, Nucleic Acids Res..

[24]  R. Tarone,et al.  Platinum-DNA adducts in leukocyte DNA correlate with disease response in ovarian cancer patients receiving platinum-based chemotherapy. , 1987, Proceedings of the National Academy of Sciences of the United States of America.

[25]  Yanhui Hu,et al.  Protein Structure Initiative Material Repository: an open shared public resource of structural genomics plasmids for the biological community , 2009, Nucleic Acids Res..

[26]  Inhibiting DNA Methylation Causes an Interferon Response in Cancer via dsRNA Including Endogenous Retroviruses. , 2015, Cell.

[27]  Amit Sharma,et al.  DNASU plasmid and PSI:Biology-Materials repositories: resources to accelerate biological research , 2013, Nucleic Acids Res..

[28]  Marco Y. Hein,et al.  The Perseus computational platform for comprehensive analysis of (prote)omics data , 2016, Nature Methods.

[29]  P. Coulie,et al.  Tumour antigens recognized by T lymphocytes: at the core of cancer immunotherapy , 2014, Nature Reviews Cancer.

[30]  Steven A Carr,et al.  Protein biomarker discovery and validation: the long and uncertain path to clinical utility , 2006, Nature Biotechnology.

[31]  P. Jeggo,et al.  ATM signaling facilitates repair of DNA double-strand breaks associated with heterochromatin. , 2008, Molecular cell.

[32]  E. Lengyel,et al.  Who are the long-term survivors of high grade serous ovarian cancer? , 2018, Gynecologic oncology.

[33]  M. Mann,et al.  Andromeda: a peptide search engine integrated into the MaxQuant environment. , 2011, Journal of proteome research.

[34]  B. Bhat,et al.  Evaluation of DNA damage using single-cell gel electrophoresis (Comet Assay) , 2011, Journal of pharmacology & pharmacotherapeutics.

[35]  Michael S. Goldberg,et al.  DNA Damage and Repair Biomarkers of Immunotherapy Response. , 2017, Cancer discovery.

[36]  A. Talerman,et al.  Ki-A10, a germ cell nuclear antigen retained in a subset of germ cell-derived tumors. , 1999, The American journal of pathology.

[37]  J. Wolchok,et al.  Genetic basis for clinical response to CTLA-4 blockade in melanoma. , 2014, The New England journal of medicine.

[38]  David Hsu,et al.  OpenComet: An automated tool for comet assay image analysis , 2014, Redox biology.

[39]  K. Odunsi,et al.  DNA hypomethylation-mediated activation of Cancer/Testis Antigen 45 (CT45) genes is associated with disease progression and reduced survival in epithelial ovarian cancer , 2015, Epigenetics.

[40]  Y. Yen,et al.  Protein phosphatase PP4 is overexpressed in human breast and lung tumors , 2008, Cell Research.

[41]  Peter A. Jones,et al.  Immune regulation by low doses of the DNA methyltransferase inhibitor 5-azacitidine in common human epithelial cancers , 2014, Oncotarget.

[42]  N. Anderson,et al.  The riddle of protein diagnostics: future bleak or bright? , 2013, Clinical chemistry.

[43]  M. Mann,et al.  Extracting gene function from protein-protein interactions using Quantitative BAC InteraCtomics (QUBIC). , 2011, Methods.

[44]  Xinxiang Li,et al.  High expression of protein phosphatase 4 is associated with the aggressive malignant behavior of colorectal carcinoma , 2015, Molecular Cancer.

[45]  M. Tiemann,et al.  Characterization and Expression of CT45 in Hodgkin's Lymphoma , 2006, Clinical Cancer Research.

[46]  Sean J Humphrey,et al.  High-throughput phosphoproteomics reveals in vivo insulin signaling dynamics , 2015, Nature Biotechnology.

[47]  Marco Y. Hein,et al.  A Human Interactome in Three Quantitative Dimensions Organized by Stoichiometries and Abundances , 2015, Cell.

[48]  D. Haussler,et al.  Exploring TCGA Pan-Cancer Data at the UCSC Cancer Genomics Browser , 2013, Scientific Reports.

[49]  L. Jensen,et al.  Mass Spectrometry of Human Leukocyte Antigen Class I Peptidomes Reveals Strong Effects of Protein Abundance and Turnover on Antigen Presentation* , 2015, Molecular & Cellular Proteomics.

[50]  Joshua M. Stuart,et al.  The Cancer Genome Atlas Pan-Cancer analysis project , 2013, Nature Genetics.

[51]  A. D’Andrea,et al.  The Fanconi anaemia pathway: new players and new functions , 2016, Nature Reviews Molecular Cell Biology.

[52]  J. Lieberman,et al.  γ-H2AX Dephosphorylation by Protein Phosphatase 2A Facilitates DNA Double-Strand Break Repair , 2005 .

[53]  K. Yamaguchi,et al.  Safety and Antitumor Activity of Anti-PD-1 Antibody, Nivolumab, in Patients With Platinum-Resistant Ovarian Cancer. , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[54]  M. Mann,et al.  MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantification , 2008, Nature Biotechnology.

[55]  P. Jeggo,et al.  Phosphoproteomic analysis reveals that PP4 dephosphorylates KAP‐1 impacting the DNA damage response , 2012, The EMBO journal.

[56]  Ruedi Aebersold,et al.  Mass-spectrometric exploration of proteome structure and function , 2016, Nature.

[57]  M. Mann,et al.  Mass Spectrometry-based Proteomics Using Q Exactive, a High-performance Benchtop Quadrupole Orbitrap Mass Spectrometer* , 2011, Molecular & Cellular Proteomics.

[58]  A. Simpson,et al.  Cancer/testis antigen CT45: Analysis of mRNA and protein expression in human cancer , 2009, International journal of cancer.

[59]  Ronald J. Moore,et al.  Integrated Proteogenomic Characterization of Human High-Grade Serous Ovarian Cancer , 2016, Cell.

[60]  Marco Y. Hein,et al.  Accurate Proteome-wide Label-free Quantification by Delayed Normalization and Maximal Peptide Ratio Extraction, Termed MaxLFQ * , 2014, Molecular & Cellular Proteomics.

[61]  Thomas M Green,et al.  A public genome-scale lentiviral expression library of human ORFs , 2011, Nature Methods.